Lunai Bioworks Inc. 8-K

What Happened
Lunai Bioworks, Inc. announced in an 8-K (filed May 20, 2026) that it intends to effect a 1-for-8 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split is expected to become effective at 12:01 a.m. Eastern Time on May 22, 2026, and the company’s common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market at the open of trading on May 22, 2026 under the existing symbol "LNAI." The company’s post-split CUSIP will be 29350E302. A press release dated May 20, 2026 was furnished as Exhibit 99.1 to the 8-K.

Key Details

• Reverse split ratio: 1-for-8 (one new share for every eight existing shares).
• Effective date/time: 12:01 a.m. Eastern Time, May 22, 2026.
• Trading: Expected to trade on a split-adjusted basis on Nasdaq at market open on May 22, 2026 under the same ticker, LNAI.
• CUSIP after split: 29350E302. Press release filed as Exhibit 99.1.

Why It Matters
A reverse stock split will reduce the number of outstanding shares and proportionally increase the per-share price. For investors, this changes share counts and the quoted share price (but not each holder’s percentage ownership in the company). The filing does not state the company’s reasons for the reverse split or provide details about treatment of fractional shares; investors should review the company’s press release (Exhibit 99.1) and any future disclosures for additional details.